One company is generating billions in revenue and raising its dividend. The other is burning cash in pursuit of a scientific breakthrough that could change how diseases are treated.
TSMC reported August 2026 revenue up 53.3% year over year, with strong margins, insider buying, and analysts maintaining a consensus Buy rating and $523.22 average price target.
A customer needs a service nearby. What happens next?A few years ago, the answer was fairly predictable. They opened Google, typed something like “electric
The Global X Robotics & Artificial Intelligence ETF (BOTZ) has fallen more than 8% over five years due to heavy industrial automation exposure, concentration risk, and weak holdings like Tesla and Baidu.
Kroger (NYSE:KR) reported modest second-quarter identical sales growth while maintaining its full-year profit outlook, as pharmacy-related pressures, a Cyclospora outbreak and cautious consumer spending weighed on the top line.
Identical sales without fuel increased 0.2% in the second quarter. Chie
Tecsys (TSE:TCS) opened fiscal 2027 with record first-quarter revenue, record adjusted EBITDA and what Chief Executive Officer Peter Brereton described as the company’s second-highest bookings quarter ever, led primarily by expansions among existing healthcare customers.
For the quarter ended July
Skyworks Solutions (NASDAQ:SWKS) Chief Executive Officer Phil Brace said the company remains confident its proposed merger with Qorvo will close within the calendar year, with the combined business expected to pursue $500 million in cost synergies and expand its reach in mobile, aerospace and defens
Hooker Furnishings (NASDAQ:HOFT) reported fiscal 2027 second-quarter net income of $1.7 million, its third consecutive profitable quarter, as tariff recoveries, prior cost reductions and improved segment profitability helped offset lower sales and continued weakness in housing and furniture demand.
Rent the Runway (NASDAQ:RENT) reported record second-quarter revenue and expanded profitability as the fashion rental platform emphasized its core rental, resale and customer-experience initiatives while pausing several noncore pilots.
The company generated $97.7 million in second-quarter revenue,
Alnylam Pharmaceuticals (NASDAQ:ALNY) has outperformed the market over the past 20 years by 6.49% on an annualized basis producing an average annual return of 15.67%. Currently, Alnylam Pharmaceuticals has a market
There is a very specific type of exhaustion that comes from worrying about money, and it usually hits the hardest at three in the morning. The rest of the
